New Insulin Price Cap Could End Up Saving Payers Money in the Long Run
HR Digest
MARCH 24, 2023
By Mark Campbell, Senior Vice President of Clinical Solutions at RxBenefits , the employee benefits industry’s first technology-enabled pharmacy benefits optimizer (PBO) Diabetes has reached epidemic proportions. The price of insulin alone skyrocketed 600% and is expected to reach nearly $24 billion by 2030.
Let's personalize your content